Adaptin Bio APTN
OTC APTN
$6.27 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Adaptin Bio (APTN) Total Non-Current Liabilities (2025 - 2026)

Updated

Adaptin Bio's Total Non-Current Liabilities came in at $2.1 million for Q2 2026, up 229.0% from $636,957 a year earlier and up 8.6% from the prior quarter.

Analysis

Adaptin Bio (APTN) Total Non-Current Liabilities (2025 - 2026) Analysis & Trends

At the end of FY2025, Adaptin Bio's Total Non-Current Liabilities was $1.56 million.

  • Business Quant data shows APTN's Total Non-Current Liabilities at $1.93 million (Q1 2026), $1.56 million (Q4 2025) and $1.31 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 105.99 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 106.45 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -967.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 36.04 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 5.92 Bn
10 Adaptin Bio 56.76 Mn 54.75 Mn - 2.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.10 Mn
Mar 31, 2026 1.93 Mn
Dec 31, 2025 1.56 Mn
Sep 30, 2025 1.31 Mn
Jun 30, 2025 636,957.00
Mar 31, 2025 557,471.00
API Access

Adaptin Bio Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=APTN&period=max&api_key=YOUR_API_KEY